We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,261 results
  1. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration

    Background and Objective

    There are some potential concerns about the currently marketed solid oral dosage forms of tramadol, including decreased...

    Naoki Ishitsubo, Shinji Oguro, ... Nobuyuki Ishibashi in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 08 December 2023
  2. Pain, Fear, Anxiety, and Stress: Relations to the Endogenous Opioid System

    Pain, fear, stress, and anxiety are separate yet interrelated phenomena. Each of these concepts has an extensive individual body of research, with...
    Nicholas J. Felicione, Melissa D. Blank, ... Daniel W. McNeil in Endogenous Opioids
    Chapter 2024
  3. The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer

    It has become apparent that endogenous opioids act not only as neurotransmitters and neuromodulators, but have multiple functions in the body....
    Gerald R. Hankins, Robert T. Harris in Endogenous Opioids
    Chapter 2024
  4. Opioid withdrawal: role in addiction and neural mechanisms

    Withdrawal from opioids involves a negative affective state that promotes maintenance of drug-seeking behavior and relapse. As such, understanding...

    Sean C. Monroe, Anna K. Radke in Psychopharmacology
    Article 10 May 2023
  5. Opioid toxicity: histamine, hypersensitivity, and MRGPRX2

    Insights into the pathophysiology of many non-immune-mediated drug reactions referred to as toxicities, sensitivities, intolerances, or...

    Brian A. Baldo, Nghia H. Pham in Archives of Toxicology
    Article 07 November 2022
  6. Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking

    Repeated exposure to opioids causes tolerance, which limits their analgesic utility and contributes to overdose and abuse liability. However, the...

    Nycole Maza, Dandan Wang, ... Kirill A. Martemyanov in Nature Neuroscience
    Article 18 August 2022
  7. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor

    New psychoactive substances (NPS) are introduced on the illicit drug market at a rapid pace. Their molecular targets are often inadequately...

    Marie H. Deventer, Mattias Persson, ... Christophe P. Stove in Archives of Toxicology
    Article 28 February 2023
  8. A dose-ranging study of the physiological and self-reported effects of repeated, rapid infusion of remifentanil in people with opioid use disorder and physical dependence on fentanyl

    Rationale

    Understanding mechanisms of drug use decisions will inform the development of treatments for opioid use disorder (OUD). Decision-making...

    Joshua A. Lile, Thomas P. Shellenberg, ... Michael J. Wesley in Psychopharmacology
    Article 22 February 2024
  9. Self-regulated Anti-Overdose Crush and Extraction-Resistant Drug Delivery System to Combat Opioid Overdose Crisis

    Pharmaceutical opioid dosage forms are commonly misused via an oral route in non-manipulated form, i.e., overdose in intact form, or manipulated...

    Patel Jayendrakumar, Patel Rakesh in AAPS PharmSciTech
    Article 26 September 2022
  10. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System

    Opioid use disorder (OUD) is defined as the chronic use or misuse of prescribed or illicitly obtained opioids and is characterized by clinically...

    Richa Jalodia, Yaa Fosuah Abu, ... Sabita Roy in Journal of Neuroimmune Pharmacology
    Article 07 January 2022
  11. The Impact of the Parenteral Opioid Medication Shortages on Opioid Utilization Practices in the Emergency Department of Two University Hospitals

    Introduction

    Both opioid and non-opioid analgesics are commonly utilized in treating acute and chronic pain in the emergency department (ED). Opioid...

    Amanda J. Deutsch, David A. Gajdosik, ... Jeanmarie Perrone in Journal of Medical Toxicology
    Article 27 April 2021
  12. Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability

    It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million Americans used...

    Cherkaouia Kibaly, Jacob A. Alderete, ... Catherine M. Cahill in Cellular and Molecular Neurobiology
    Article 27 November 2020
  13. Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity

    Opioid-induced respiratory depression is potentially life-threatening and often regarded as the main hazard of opioid use. Main cause of death is...

    Brian A. Baldo in Archives of Toxicology
    Article 11 May 2021
  14. Pain-induced impulsivity is sexually dimorphic and mu-opioid receptor sensitive in rats

    Rationale and objectives

    Pain sensation can negatively impact cognitive function, including impulsivity. Pain-induced changes in impulsivity can...

    Nidia Espinoza Serrano, Samuel G. Saputra, ... Arbi Nazarian in Psychopharmacology
    Article 24 August 2021
  15. Endogenous and Exogenous Opioids: Role in Substance Use Disorders

    Opioid use disorders have become an epidemic in recent years with rates nearly quadrupling since 1999 according to the US Centers for Disease Control...
    Lindsay Acree in Endogenous Opioids
    Chapter 2024
  16. Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes

    Aims

    Intravenous (IV) misuse of the µ opioid analgesic oxymorphone has caused significant public health harms; however, no controlled data on its IV...

    Shanna Babalonis, Sandra D. Comer, ... Sharon L. Walsh in Psychopharmacology
    Article 01 June 2021
  17. Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidental Overdose or Abuse of Drugs

    Death from an accidental or intentional overdose of slee** tablets has increased exponentially in the USA. Furthermore, the simultaneous...

    Manali Patki, Siddhant Palekar, ... Ketankumar Patel in AAPS PharmSciTech
    Article 25 November 2020
  18. Opioid Use and Driving Performance

    Introduction

    The USA is in an opioid epidemic, with an increased number of individuals taking psychoactive drugs while executing the tasks of everyday...

    Keaton T. Cameron-Burr, Albert Conicella, Mark J. Neavyn in Journal of Medical Toxicology
    Article 05 January 2021
  19. Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

    The use of morphine as a first-line agent for moderate-to-severe pain is limited by the development of analgesic tolerance. Initially opioid receptor...

    Laura J. Gledhill, Anna-Marie Babey in Cellular and Molecular Neurobiology
    Article 11 March 2021
  20. Opioid and neuroHIV Comorbidity – Current and Future Perspectives

    With the current national opioid crisis, it is critical to examine the mechanisms underlying pathophysiologic interactions between human...

    Sylvia Fitting, MaryPeace McRae, Kurt F. Hauser in Journal of Neuroimmune Pharmacology
    Article Open access 02 September 2020
Did you find what you were looking for? Share feedback.